Kodiak Sciences (KOD) Expected to Announce Earnings on Thursday

Kodiak Sciences (NASDAQ:KOD) is projected to announce its earnings results before the market opens on Thursday, March 27th. Analysts expect the company to announce earnings of ($0.87) per share for the quarter.

Kodiak Sciences Trading Up 7.3 %

Shares of NASDAQ KOD opened at $3.52 on Tuesday. The firm has a fifty day simple moving average of $5.23 and a two-hundred day simple moving average of $5.43. The firm has a market capitalization of $185.24 million, a PE ratio of -0.96 and a beta of 2.26. Kodiak Sciences has a 12 month low of $2.19 and a 12 month high of $11.60.

Analyst Ratings Changes

Separately, Jefferies Financial Group raised Kodiak Sciences from a “hold” rating to a “buy” rating and set a $20.00 price objective on the stock in a research report on Monday, December 9th.

Kodiak Sciences Company Profile

Kodiak Sciences Inc, a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is tarcocimab tedromer (KSI-301), an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as well as Phase III clinical study for the treatment of diabetic macular edema, naïve macular edema due to retinal vein occlusion, and non-proliferative diabetic retinopathy.